Bluejay Therapeutics Funding: $243M Raised, Series C (2024)

Bluejay Therapeutics funding overview

Bluejay Therapeutics is a Biotech company based in San Mateo, California. Bluejay Therapeutics has raised $243M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in May 2024. The round record for Bluejay Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include T. Rowe Price, RA Capital, Mirum Pharmaceuticals, Arkin Bio Ventures, HBM Healthcare Investments, Synergenics LLC and 4 others. 10 distinct backers are named across the disclosed rounds.

Bluejay Therapeutics at a glance

Total raised: $243M
Latest round: Series C
Latest round date: May 2024
Industry: Biotech
Headquarters: San Mateo, California
Notable investors: T. Rowe Price, RA Capital, Mirum Pharmaceuticals, Arkin Bio Ventures, HBM Healthcare Investments, Synergenics LLC, RiverVest Venture Partners, Yonjin Capital

Frequently asked about Bluejay Therapeutics funding

How much has Bluejay Therapeutics raised?: Bluejay Therapeutics has raised $243M in total disclosed funding across the rounds on record.
Who has invested in Bluejay Therapeutics?: T. Rowe Price, RA Capital, Mirum Pharmaceuticals, Arkin Bio Ventures, HBM Healthcare Investments, Synergenics LLC are named among the investors backing Bluejay Therapeutics.
What was the latest Bluejay Therapeutics funding round?: The most recent disclosed round is a Series C, announced in May 2024.
Where is Bluejay Therapeutics based?: Bluejay Therapeutics is based in San Mateo, California.
What sector does Bluejay Therapeutics operate in?: Bluejay Therapeutics is tracked under Biotech from San Mateo, California, with $243M in disclosed funding.
When did Bluejay Therapeutics last raise?: The last disclosed Bluejay Therapeutics round closed in May 2024 at Series C.

Round data for Bluejay Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in San Mateo and backer lists below.

Bluejay Therapeutics Funding: $243M Raised, Series C (2024)

Bluejay Therapeutics funding overview

Bluejay Therapeutics at a glance

Frequently asked about Bluejay Therapeutics funding

Bluejay Therapeutics founders (1)

Companies related to Bluejay Therapeutics (40)

Browse related funding lists (6)